No Data
No Data
No Data
No Data
No Data
Genetic Signatures Appoints Interim CEO
Molecular diagnostics company Genetic Signatures (ASX:GSS) named Neil Gunn as interim CEO following the resignation of John Melki from the role and from the board of directors, according to a Tuesday
MT NewswiresApr 30 08:26
Genetic Signatures' Sales Drop in Fiscal Q3
Genetic Signatures (ASX:GSS) logged sales of AU$1.7 million for the third quarter of fiscal 2024, down from AU$2 million in the year-ago period, according to an April 26 filing with the Australian bou
MT NewswiresApr 29 05:51
Genetic Signatures Secures TGA Approval for Updated EasyScreen Respiratory Pathogen Detection Kit Sale in Australia
Diagnostics company Genetic Signatures (ASX:GSS) obtained authorization from the Therapeutic Goods Administration for the supply of its redesigned EasyScreen Respiratory Pathogen Detection Kit in Aust
MT NewswiresApr 22 08:03
Genetic Signatures Price Target Cut 6.3% to A$0.75/Share by Bell Potter
Genetic Signatures Price Target Cut 6.3% to A$0.75/Share by Bell Potter
Dow JonesFeb 2 06:31
Genetic Signatures Completes Rights Issue
Genetic Signatures (ASX:GSS) completed an underwritten rights issue on Jan. 18, the molecular diagnostics company said Wednesday. The rights issue closed with valid applications for entitlements of AU
MT NewswiresJan 24 12:49
Genetic Signatures Target Price Cut 3.6% to A$0.80/Share by Bell Potter>GSS.AU
Genetic Signatures Target Price Cut 3.6% to A$0.80/Share by Bell Potter>GSS.AU
Dow JonesJan 22 07:46
No Data
No Data